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ABSTRACT
Peptides derived from egg whites by thermolysin digestion were fractionated and characterized to investigate their inhibitory
activity against angiotensin I-converting enzyme (ACE). The antihypertensive effect of egg white hydrolysates in strain SHR
spontaneously hypertensive rats was also investigated. At optimal conditions, pH 8, 60°C, and (E)/(S) = 0.02%, digestion of 1%
crude egg white solution by thermolysin was carried for 4 hours. The recovery yield from the supernatant after centrifugation was
around 80%. The hydrolysate showed high ACE inhibitory activity (IC50 = 33 μg/mL) and imparted neither bitter taste nor the iron
odor of egg whites. Sequential ultra-filtration of hydrolysate with MW cut-off 10,000, 3,000 and 1,000 Da resulted in increased
activity from each filtrate up to IC50 = 17 μg /mL. Thermolysin was recycled from the hydrolysate for subsequent batch use for a
total of four batches without reduction in anti-hypertensive activity. The hydrolysate demonstrated an anti-hypertensive activity in
spontaneously hypertensive rats at an orally administrated dosage of 0.2 g/kg body weight.
Key words: angiotensin I-converting enzyme (ACE), antihypertensive activity, protein hydrolysate, egg whites.

INTRODUCTION
Peptides derived from food protein hydrolysates as
potential nutraceuticals have been extensively studied for
many years. Among the peptides with anti-hypertensive
activity, angiotensin I converting enzymes (ACE) inhibitors have been obtained from the proteolytic products
of many food proteins (1-2). Studies on ACE inhibitory
peptides have been focused mainly on the activities of
purified peptides and their structure. Ovokinin, a pentapeptide with anti-hypertensive effect, has been isolated
and characterized f rom ovalbumin tr y ptic hydrolysate (3-4). Potent derivatives have been designed from
ovokinin (5-6). Gene encoded ovokinin (2-7) has been
incorporated in soybeans to create modified soybean
protein with anti-hypertensive activity (7). Regarding
the application of anti-hypertensive substances as functional foods, the production of active peptide fractions
is more important than the active peptide purification.
A few antihypertensive functional foods from casein
hydrolysates, soy isolate and banito have been developed in Japan (8). In the production of active peptides,
high peptide productivity, protein source and proteolytic
enzyme availability must be fulfilled. High productivity
can be achieved by producing more active peptide fractions at higher yield. The cost for the protein source and
proteolytic enzyme should be kept sufficiently low for
industrial use.
In 2004, 23.5 million laying birds in Taiwan produced
256 eggs each. The average annual egg consumption per
* Author for correspondence. Tel: +886-4-23506747;
Fax: +886-4-23506747; E-mail: tct1@thu.edu.tw

person in this country is up to 275 eggs(9). The egg industry is important to farmers and eggs are an important
animal protein source for people. Eggs contain a variety
of proteins that own unique functional and nutritional
properties. The egg white is a superior foaming agent in
baking, whereas the egg yolk is an excellent emulsifier for
mayonnaise(10). To make its application simple in various
food processing, the egg white and egg yolk are usually
separated and packaged in the egg processing industry.
The egg contains all of the essential amino acids and is
commonly used as a standard for protein quality assessment(11). Because of its balanced amino acids, the egg has
been investigated to produce hydrolysate as nutraceuticals
with or without anti-hypertensive activity (12-13). This
study further evaluates batch production of nutraceutical
hydrolysates with anti-hypertensive activity using thermolysin as proteolytic enzyme.

MATERIALS AND METHODS
I. Enzymes and Chemicals
Thermolysin (from Bacillus thermoproteolyticus
rokko) and ACE obtained from rabbit lungs, hippury-Lhistidyl-L-leucine (HHL), hippuric acid (HA), molecular
weight markers including cytochrome C, aprotinin, gastrin
I, substance P, triglycine and glycine were purchased
from Sigma Chemical Co. (St. Louis, MO, USA) or Merck
(Damdstadt, Germany). Regenerated cellulose ultra-filtration membranes were obtained from Millipore Corporation (Bedford, MA, USA).
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II. Preparation of Hydrolysates
1.0% (w/v) crude egg white and 0.2% (w/w of egg
white) thermolysin was employed to produce hydrolysate.
The temperature and pH for thermolysin was determined
in our previous study to be 65°C and 8.0, respectively.
The pH of egg white solution was adjusted to be 8.0 with
1 N NaOH and heated to 65°C before thermolysin addition. Sample aliquots, withdrawn at 10, 20, 30, 60, 120,
180 and 240 min from proteolytic mixture, were immediately heated in a boiling water bath for 10 min. Parts of
heated mixtures were used for measurement of their pH
and degree of hydrolysis (DH). The rest of heated mixture
was subjected to centrifugation at 10,000 ×g in a microcentrifuge for 10 min. The supernatants were assayed for
their ACE inhibitory activity. The DH at any time was
measured by orthophthaldialdehyde (OPA) method(14).
III. Assay for ACE Inhibitory Activity
ACE inhibitory activity was analyzed spectrophotometrically using HHL as the substrate according to the
method of Cushman and Cheung(15). HHL was prepared
with 0.1 M sodium borate buffer (pH 8.3) containing
0.4 M NaCl. ACE from rabbit lung was dissolved in the
same buffer at a concentration of 60 mU/mL. A mixture
containing 225 μL of HHL solution and 25 μL of protein
hydrolysate was incubated at 37°C for 5 min. 75 μL of
ACE solution was then added in and the incubation was
extended for 30 min. The reaction was stopped with 20
μL of 0.1% trifluoroacetic acid (TFA). HA liberated by
ACE was determined by RP-HPLC on a LiChrospher
C18 column (4 × 250 mm, Merck, Germany). The mobile
phase was 0.1% TFA in 50% methanol with a flow-rate of
0.8 mL/min. The effluent was monitored with an ultraviolet detector (Shimadzu, Tokyo, Japan) at 228 nm. The
IC50 value was defined as the concentration of ACE inhibitor or protein hydrolysate needed to reduce the height of
the HA peak to 50%, and determined by regression analysis of ACE inhibitory activity (%) versus protein concentration. The IC50 value was expressed as mg protein/mL.
ACE inhibitory activity (%) was expressed as
ACE Inhibitory Activity (%) = (Ho – Hp) x 100 / Ho
Where Ho is the height of HA peak without protein
hydrolysate; H p is the height of HA peak with protein
hydrolysate.
IV. Effect of Differential Ultrafiltration Membranes on ACE
Inhibitory Activity
Hydrolysates generated by enzymatic hydrolysis
were subjected to sequential ultra-filtration using regenerated cellulose discs with 10, 3 and 1 kDa molecular weight
cut-offs (MWCO), individually. Each permeate was
collected for the determination of protein concentration,

profile of molecular weight distribution and IC50 for ACE
inhibitory activity.
V. Molecular Weight Distribution
The molecular weight distribution of the hydrolysate was analyzed by high-performance size-exclusion
chromatography (HPSEC). The HPSEC consisted of a
Superdex peptide 10/300 GL column, connected to a UV
detector set at 214 nm. The mobile phase was 0.02 M
phosphate buffer (pH 7.2) containing 0.25 M NaCl and the
flow rate was set at 0.5 mL/min.
VI.Recycling Thermolysin for Batch Process
The batch reactor is a reaction vessel (250 mL) with
a hot water jacket on stir to provide uniform heating
and mixing. One hundred milliliters of 1% egg white
(pH 8.0) and thermolysin was introduced into the reaction vessel and the mixture was heated. After egg white
digestion at optimal condition for 4 hr, the hydrolysate
was centrifuged (3,000 ×g) and the supernatant was
subjected to ultra-filtration through a membrane with a 3
kDa MWCO. The permeate (about 80% in volume) was
recovered for the measurement of ACE inhibitory activity and total nitrogen. The retentate (20% in volume)
above the membrane, which contains the thermolysin,
was recycled for subsequent batch hydrolysis. The recycling of thermolysin for batch hydrolysis was repeated
for three times
VII. Preparation of Hand-Shaken Multi-Lamellar Vesicles
(MLVs)(16)
Three mL of chloroform solution containing 300
μmole lipid (lecithin:cholesterol = 1:0.25) was rotor-evaporated to form a thin film in round flask under vacuum.
Two mL of phosphate buffered saline containing supernatant hydrolysate without further fractionation was added
into flask. After addition of few glass beads (1.4 cm in
diameter), the whole solution was shaken at 50°C in water
bath for 5 min to make the multi-lamellar vesicles. After
cooling at room temperature for 10 min, the MLV liposome solution was ready to use.
VIII. Measurement of Blood Pressure(17)
Male SHR were purchased from National Laboratory
Animal Center (Taipei, Taiwan, ROC). Systolic blood
pressure (SBP) of SHR, 7 to 8 wks of age (250 to 300 g
body weight), were measured as follows. Rats that had
been given each hydrolysate by gastric intubation were
kept at 37°C for 5 min, and the SBP were measured by tail
cuff with a programmed electro-sphygmomanometer (MK
1030, Muromachi Co. LTD, Japan). Phosphate buffered
saline (0.15 M NaCl and 0.01 M phosphate buffer, pH 7.4)
containing egg whites was used as a control, and the anti-
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RESULTS AND DISCUSSION
I. Degree of Hydrolysis and ACE Inhibitory Activity of
Hydrolysate
Thermolysin (EC 3.4.24.27) from Bacillus thermoproteolyticus rokko, is a thermostable extra cellular metalloendopeptidase(18) containing four calcium ions. Cofactors
are zinc and calcium(19-20). The thermolysin hydrolyzes
peptide bonds on N-terminal sides of hydrophobic amino
acid residues (21). Its optimal pH and temperature for
activity were 8.0 and 65-70°C, respectively. Thermolysin
is stable from pH 5 to 9.5. Thermolysin has low cleavage specificity, therefore it produces a number of short
fragments. The thermolysin preferential cleavage site:
X-cleavage-Y-Z, where X = any amino acid, Y = Leu, Phe,
Ile, Val, Met, Ala, and Z is any amino acid other than Pro.
Four proteases including alcalase, esperase, thermolysin
and chymotrypsin have been used to hydrolyze egg white
in previous study and thermolysin is the most potent one
(data not shown) because of its low specificity. Enzymatic
hydrolysis is very costly due to the cost of enzyme. Low
dosage of thermolysin was employed in this investigation.
The change in pH, degree of hydrolysis (DH) and
ACE inhibition of hydrolyzed mixture during hydrolysis
process are shown in Figure 1. The pH dropped quickly
from 8 to 6.6 in first 30 min during digestion process and
then slowly dropped down to 6.5 in 4 hr.
Production of peptide fragments during digestion
process shall increase in acidity. The decrease in protein
concentration and the increase in acidity would lower the
enzymatic activity, and thus slow down the drop in pH.
Activity of thermolysin will remain 60% at pH 6.5. The
pH control of hydrolysis mixture by controller during
digestion would be an effective way to improve the enzymatic activity. Conversely, the DH during the digestion
process increased rapidly from 0 to 11.4% in the initial
30 min. and then slowly increased to 15.1% in 4 hr. Quite
similar to the change in DH, ACE inhibitory activity of
10-fold diluted hydrolysate mixture increased rapidly to
57% in first 30 min, 60% in next 30 min and kept almost

II. Characteristics of Hydrolysate
The clear hydrolysate solution exhibited a very light
peptone odor and no bitter taste. The color attributes, L,
a and b, for hydrolysate solution and hydrolysate powder
were 99.3, -0.9, 5.8 and 93.1, -1.2, 4.93, respectively. The
hydrolysate will impart neither color nor f lavor to the
product when added as a food additive. Most protein
hydrolysate with other enzymes, especially bacterial
enzyme, will give a bitter flavor. The bitter taste of hydrolysate would limit its use as food additive or consumption
as it is. The bland f lavor of the egg white hydrolysate
digested by thermolysin is due to its special enzymatic
specificity, i.e. thermolysin hydrolyzes the peptide bond
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Sensory evaluation for flavor, color and oval acceptance using a 5-point hedonic scale to determine differences among the treatments were carried out by a group
of 10 graduate st udents in the Depar tment of Food
Science, Tunghai university. The experimental data were
analyzed by variance analyses with significance defined
at p < 0.05. All statistical analyses were performed with
Statistical Analysis System software (SAS Institute Inc.,
Cary, N.C., USA)
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IX. Statistical Analysis

steady state in following hour digestion. All of these
changes in pH, DH and ACE inhibitory activity were of
typical enzymatic digestion and of hyperbolic function of
the process time. Four hour hydrolysis was considered to
be enough for this process.
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hypertensive effects of the hydrolysate powder dissolved
in this buffer were measured.
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Figure 1. The time course of changes of pH, degree of hydrolysis
and ACE inhibitory activity of egg white solution hydrolyzed by
thermolysin.
 Degree of hydrolysis
 ACE inhibition of original hydrolysate
pH value
 ACE inhibition of 10 × fold diluted hydrolysate
Table 1. Sensory evaluation of skim milk and skim milk containing
egg white hydrolysate.
Odora

Bitternessb

Overall
acceptabilityc

Skim milk

2.00 ± 0.45x

1.44 ± 0.53x

3.70 ± 0.48x

Skim milk
containing egg
white hydrolysate

2.33 ± 0.82x

1.50 ± 0.53x

3.56 ± 0.53x

Product

Mean values in the same column that are followed by different
letters are significantly different. (p < 0.05)
a
A five-point scale (5 = extremely smell, 4 = moderate smell, 3 =
slightly smell, 2 = trace of smell, 1 = no smell).
b
A five-point scale (5 = extremely bitter, 4 = moderate bitter, 3 =
slightly bitter, 2 = trace of bitterness, 1 = no bitter).
c
A five-point scale (5 = like very much, 4 = like slightly, 3 = neither
like or dislike, 2 = dislike slightly, 1 = dislike very much).

388
Journal of Food and Drug Analysis, Vol. 14, No. 4, 2006

IV. Recycling Thermolysin for Batch Process
Contrary to most biological enzymes, thermolysin is considerably stable at below 70°C. Its molecular
weight is around 34.6 kDa. Thermolysin could be easy
to recover from hydrolysate by ultra-filtration for reuse.
Peptide concentration and ACE inhibitory activity of 10
× fold diluted hydrolysate from batch process by recycled
thermolysin are shown in Figure 3. Both clear hydrolysates and permeate from membrane of 3 kDa MWCO
have same ACE inhibitory activity and exhibited almost
same activity through four batch processes. The result
implied that ACE inhibitory activity of hydrolysate is
from small peptides with molecular weight less than 3
kDa. That means that ultra-filtering to recycle thermolysin did not reduce the ACE inhibitory activity of perme-

Protein Inhibition 10X
recovery
dilution

IC50

mg/100mL

%

%

μg/mL
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Fig ure 2. T he molecula r weig ht dist r ibut ion of egg wh ite
hydrolysate supernatant and permeates obtained from reactor with
different MWCO membranes.
Mr Standard: (1) Cytocrome C, Mr = 12,500; (2) Gastrin, Mr =
2,126; (3) Substonce P, Mr = 1,384; (4) (Glycine)6, Mr = 360; (5)
(Glycine)3, Mr = 189; (6) Glycine, Mr = 75.
100

25

90
20

80
70

15

60
50

10

40
30

Peptide conc. (mM)

It is generally recognized that only small peptide
(MW < 1 kDa) will exert ACE inhibitory activity. A
simple and effective way to separate the small peptide
fraction is to filter the hydrolysate through a membrane
disc with suitable MWCO. The peptide yield and ACE
inhibitory activity of each permeate obtained by sequential ultra-f iltering hydrolysate with 10, 3 and 1 kDa
MWCO membranes are shown in Table 2. The ACE
inhibitory activities of permeate increased with a decrease
in MWCO. IC50 of fractions of permeate through 3 and
1 kDa MWCO membrane were 25 and 14 μg/mL, respectively. The molecular weight distribution of hydrolysate
and its permeates from different MWCO membranes are
shown in Figure 2. The peptide with molecular weight
larger than 10 kDa has been completely removed by 10
kDa MWCO membrane. The molecular distribution
profile of 3 kDa permeates is quite similar to that of 1 kDa
permeate. For safe recycling of thermolysin for subsequent use and saving processing time, membrane with
3 kDa MWCO was chosen to use in batch production of
hydrolysate with ACE inhibitory activity.
Tryptic casein hydrolysate with an IC50 value of 166
μg protein/mL has been reported to have an anti-hypertensive effect in spontaneously hypertensive rate(22). The
IC50 values obtained from ultra filtered tryptic digests of
milk protein range from 130-210 μg protein/mL and this
indicated the potential of such protein hydrolysates as
nutraceuticals in prevention of hypertension(23). The IC50
values for the hydrolysates and permeates reported herein
are even lower and the hydrolysates likely mediate an antihypertensive effect in spontaneously hypertensive rats.

Protein
content

Fraction

A 214

III. Fractionation of Hydrolysate and Inhibitory Activity

Table 2. The peptide content, yield and IC50 value of egg white
hydrolysate and its permeates, respectively, filtered by different
MWCO membranes.

ACE inhibitiory activity (%)

on the N-terminal site of hydrophobic amino acid residues. The sensory evaluation of skim milk and skim milk
containing 1% egg white hydrolyste powder is shown in
Table 1. No significant difference could be found in odor,
bitterness and overall acceptability between skim milk
and skim milk containing hydrolysate.
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Figure 3. Peptide concentration and ACE inhibitory activity of
hydrolysate from batch process by recycled thermolysin
 ACE inhibitory activity of 10 fold diluted 3 kDa permeate
 A
 CE inhibitory activity of 10 fold diluted supernatant from
centrifugation
P
 eptide concentration of 10 fold diluted supernatant after
centrifugation
 Peptide concentration of 10 fold diluted 3kDa permeate
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ate. The peptide concentrations in both clear hydrolysate
and permeate are increased as the number of thermolysin
recycling increases. The peptide concentration in hydrolysate is more than double that of permeate in all batch
processes. Increase in peptide concentration in hydrolysate would render ultra-filtering more difficult and more
time-consuming. More than four recycling of thermolysin is likely feasible for batch process and the cost of the
hydrolysis will be greatly reduced.
V. Changes of SBP of SHR after Administration of the
Hydrolysate
At 0, 2, 4, 6 and 8 hr after oral administration of the
hydrolysates or liposome encapsulated hydrolysate, SBP
were measured in SHR rats (Figure 4). In the control, no
changes in SBP occurred within 8 hr after administration.
However, the peptides by thermolysin showed potent antihypertensive activity in SHR rats (186 mg of peptide/kg
of body weight) 2 hr after administration (-26.7 mmHg).
At 4, 6 and 8 hr after administration, these peptides also
exerted potent anti-hypertensive activity (-23, -20 and -13
mmHg, respectively). No significant difference is found
between two dosages: 186 mg and 372 mg of peptide/kg of
body weight. MLVs-peptide showed better effect on the
anti-hypertensive activity than peptide only. Liposomeencapsulation has been employed to deliver drugs to the
target because lipsome is resistant to peptic digestion and
enhances intestinal absorption(24-25). These peptides had
an anti-hypertensive effect that is dependent on the dose
and the preparation given to SHR rats.

0

Changes in SBP (mmHg)

-5

-15

-25

-35

0

2

4

6

8

Time after administration (h)
Figure 4. Antihypertensive effect of a single oral administration
of hydrolysate in spontaneous hypertensive rats(SHR). Each point
is the mean of the changes of systolic blood pressure(SBP) of five
SHR.
control
0.372 g peptide/kg
0.372 g peptide in lipsome/kg
0.186 g peptide/kg

CONCLUSIONS
Thermolysin showed high efficiency egg white digestion. Egg white hydrolysate using thermolysin is almost
white in color and bland in flavor and can be used as a
nutraceutical. The peptide mixture in the hydrolysate
exhibited strong ACE inhibition activity. The main active
peptides in hydrolysate were relatively short with MW
below 1kDa. The peptide mixture in the hydrolysate
showed a potent anti-hypertensive effect on SBP in SHR
rats at 0.18 g/kg of body weight. Recycling thermolysin
for peptide mixture batch production was feasible and
could be repeated many times to reduce the production
cost. These hydrolysate peptide mixtures could be used
as a health food additive for hypertensive patients.
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